Artelo Biosciences, Inc.
ARTL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001621221
No open-market purchases or sales by Artelo Biosciences, Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $132.0K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Artelo Biosciences, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 9
- 0 vs. Q2 2025
- Shares held
- 33.0K
- +16.5K (+99.2%) vs. Q2 2025
- Total value
- $151.7K
- −$68.5K (−31.1%) vs. Q2 2025
- New holders
- 3
- 5 more added
- Sold out
- 3
- 0 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ARTL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $132.0K |
| Q1 2026 | 11 | $829.9K |
| Q4 2025 | 10 | $120.6K |
| Q3 2025 | 9 | $151.7K |
| Q2 2025 | 9 | $220.1K |
| Q1 2025 | 8 | $75.8K |
| Q4 2024 | 6 | $36.6K |
| Q3 2024 | 5 | $25.6K |
| Q2 2024 | 6 | $35.7K |
| Q1 2024 | 7 | $37.2K |
| Q4 2023 | 7 | $34.4K |
| Q3 2023 | 8 | $76.4K |
| Q2 2023 | 6 | $78.4K |
| Q1 2023 | 7 | $110.8K |
| Q4 2022 | 8 | $337.9K |
| Q3 2022 | 9 | $464.0K |
| Q2 2022 | 15 | $442.8K |
| Q1 2022 | 18 | $659.0K |
| Q4 2021 | 22 | $992.0K |
| Q3 2021 | 17 | $1.57M |
| Q2 2021 | 20 | $3.29M |
| Q1 2021 | 15 | $2.17M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Artelo Biosciences, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| DRW Securities, LLC | 17,185 | $78.9K | 0.00% | +17,185 | New |
| Vanguard Group Inc | 14,028 | $64.4K | 0.00% | +14,028 | New |
| Morgan Stanley | 1,100 | $5.05K | 0.00% | +1,096+27,400.0% | Added |
| Citigroup Inc | 477 | $2.19K | 0.00% | +468+5,200.0% | Added |
| UBS Group AG | 209 | $959 | 0.00% | +120+134.8% | Added |
| FMR LLC | 30 | $138 | 0.00% | +29+2,900.0% | Added |
| Bank of America Corp | 11 | $50 | 0.00% | +6+120.0% | Added |
| Rothschild Investment LLC | 2 | $9 | 0.00% | +2 | New |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −16,032−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −447−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −1−100.0% | Sold out |